Metabolites in safety testing: metabolite identification strategies in discovery and development
Open Access
- 1 May 2009
- journal article
- invited reviews-on-metabolite-in-safety-testing
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 30 (4) , 153-162
Abstract
The publication of the FDA MIST guidelines in 2008, together with the acknowledged importance of metabolism data for the progression of novel compounds through drug discovery and drug development, has resulted in a renewed focus on the metabolite identification strategies utilised throughout the pharmaceutical industry. With the plethora of existing and emerging technologies available to the metabolite identification scientist, it is argued that increased diligence should be applied to metabolism studies in the early stages of both drug discovery and drug development, in order to more routinely impact chemical design and to comply with the concepts of the MIST guidance without re‐positioning the definitive radiolabelled studies from there typical place in late development.Furthermore, these strategic elements should be augmented by a broad and thorough understanding of the impact of the derived metabolism data, most notably considerations of absolute abundance, structure and pharmacological activity, such that they can be put into proper context as part of a holistic safety strategy.The combination of these approaches should ensure a metabolite identification strategy that successfully applies the principles of the MIST guidance throughout the discovery/development continuum and thereby provides appropriate confidence in support of human safety. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 49 references indexed in Scilit:
- Which Human Metabolites Have We MIST? Retrospective Analysis, Practical Aspects, and Perspectives For Metabolite Identification and Quantification in Pharmaceutical DevelopmentChemical Research in Toxicology, 2009
- Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating MetabolitesChemical Research in Toxicology, 2009
- In Vitro Screening Techniques for Reactive Metabolites for Minimizing Bioactivation Potential in Drug DiscoveryCurrent Drug Metabolism, 2008
- Metabolism and Toxicity of Drugs. Two Decades of Progress in Industrial Drug MetabolismChemical Research in Toxicology, 2007
- Analytical strategies for identifying drug metabolitesMass Spectrometry Reviews, 2007
- A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analysesJournal of Mass Spectrometry, 2003
- Liquid chromatography/atmospheric pressure ionization–mass spectrometry in drug metabolism studiesJournal of Mass Spectrometry, 2003
- Peer Reviewed: Systematic LC/MS Metabolite Identification in Drug DiscoveryAnalytical Chemistry, 2001
- Quantification and Rapid Metabolite Identification in Drug Discovery Using API Time-of-Flight LC/MSAnalytical Chemistry, 2000
- Use of electrospray ionization and neutral loss liquid chromatography/tandem mass spectrometry in drug metabolism studiesJournal of Mass Spectrometry, 1995